25 recruiting, 12 active not recruiting, 10 not yet recruiting, 9 completed. 72 Not applicable.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 72 | Recruiting 25, Active not recruiting 12, Not yet recruiting 10, Completed 9, Withdrawn 9, Unknown 4, Terminated 2, Suspended 1 |
Follow Triple Negative Breast Neoplasms: new trials by email Literature Review of Triple Negative Breast Neoplasms trials Research Report on Triple Negative Breast Neoplasms
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Fasten Onco Digital Therapy During Neoadjuvant Treatment for Triple-Negative Breast Cancer Fasten Onco, Standard Neoadjuvant Treatment - Triple-Negative Breast Cancer (TNBC) | Not applicable | Not yet recruiting | FASTEN | 144 | 2026-10-30 | 2026-10-21 |
| Emergence of Predictive Metabolomic Biomarkers of Response to Neoadjuvant Chemoimmunotherapy in Triple-Negative Breast Cancer. Blood sampling, Tumor sampling - Triple-negative Breast Cancer (TNBC), Stage II-III | Not applicable | Not yet recruiting | Centre Antoine Lacassagne | 50 | 2026-10-01 | 2026-09-29 |
| A Blended e-Health Intervention to Improve Fear of Progression in Women With Gynecologic or Breast Cancer Best Practice, Interview, Supportive Care - Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage II Breast Cancer AJCC v8 | Not applicable | Recruiting | City of Hope Medical Center | 126 | 2026-09-09 | 2026-10-16 |
| Study of the TheraBionic P1 Device in Patients With Metastatic Triple Negative Breast Cancer After Progression TheraBionic P1 - Triple Negative Breast Cancer | Not applicable | Not yet recruiting | Barbara Ann Karmanos Cancer Institute | 24 | 2026-09-01 | 2026-06-29 |
| ON-treatment Single-cell Analysis for the Identification of Early Tumor Response Biomarkers on Prospective Collected Serial Tumor Biopsies in Triple Negative Breast Cancer Patient During Standard Neoadjuvant Chemo-immunotherapy on treatment biopsy (after C1) - Breast Cancer Early Stage Breast Cancer (Stage 1-3) | Not applicable | Not yet recruiting | IRCCS San Raffaele | 55 | 2026-09-01 | 2026-05-22 |
| Omission of Surgery for Triple-negative Breast Cancer in Complete Response After Neoadjuvant Chemo-immunotherapy Omission of surgery - Triple Negative Breast Cancer, Non-Metastatic | Not applicable | Not yet recruiting | Institut Curie | 150 | 2026-08-01 | 2026-06-03 |
| Use of Magtrace Bracketing for Excision of Lesion and Sentinel Lymph Node Localization in Breast Conserving Surgery for Breast Cancer Super paramagnetic iron oxide bracketing injection - Breast Cancer With Low to Intermediate HER2 Expression, Breast Cancer (Triple Negative Breast Cancer (TNBC)) | Not applicable | Recruiting | King Faisal Specialist Hospital & Research Center | 35 | 2026-07-24 | 2026-09-28 |
| Virtual Mental Health Intervention to Address Fear of Progression for Women With High Risk or Stage III-IV Gynecologic or Breast Cancer Behavioral Intervention, Educational Intervention, Internet-Based Intervention - Anatomic Stage III Breast Cancer AJCC v8, Anatomic Stage IV Breast Cancer AJCC v8 | Not applicable | Withdrawn | City of Hope Medical Center | 2026-07-16 | 2026-02-04 | |
| A Nurse-Led, Coping and Supportive Intervention for Patients With Triple-Negative Breast Cancer RESTORE, Enhanced Usual Care - Triple Negative Breast Cancer (TNBC) | Not applicable | Recruiting | Massachusetts General Hospital | 75 | 2026-07-07 | 2026-09-15 |
| Circulating Tumor DNA Based Minimal Residual Disease Detection for Patients With Early-Stage Breast Cancer Biospecimen Collection, Electronic Health Record Review, Survey Administration - Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage II Breast Cancer AJCC v8 | Not applicable | Withdrawn | City of Hope Medical Center | 2026-05-12 | 2026-06-25 | |
| Early Detection of Metastatic Recurrence Among Patients With Stage II or III Triple Negative Breast Cancer Using Liquid Biopsy and Imaging ctDNA-guided imaging surveillance, Standard - Triple Negative Breast Cancer, Surveillance | Not applicable | Not yet recruiting | Sunnybrook Health Sciences Centre | 30 | 2026-05-01 | 2026-03-17 |
| A Synthetic Lethality-Focused Algorithm to Identify Therapeutic Options in Advanced Metastatic Breast Cancer (SYNTHESIS-Breast) Expression Networks for highLIGHting Tumor vulnerabilities (ENLIGHT), TruSight(R) Oncology 500, TruSeq Matched Tumor Normal Whole Exome Sequencing Assay - Breast Cancer, Breast Carcinoma | Not applicable | Recruiting | National Cancer Institute (NCI) | 175 | 2026-02-23 | 2026-08-21 |
| Metabolic Flexibility in Patients With Early Triple-negative Breast Cancer Cardiovascular training at maximal fat oxidation (FATmax), Cardiovascular training at maximal aerobic power (MAP), Resistance training - Triple-Negative Breast Cancer (TNBC) | Not applicable | Active not recruiting | Universidad Europea de Madrid | 40 | 2026-02-10 | 2026-03-20 |
| Physical Activity and Healthy Aging: Promoting Cardio-metabolic Capacity to Fight Chronic Inflammation and Improve Outcomes in Breast Cancer Patients (PhActHealth Study) Pre-habilitation exercise program - Breast Cancer | Not applicable | Recruiting | University of Milan | 126 | 2026-02-01 | 2026-08-20 |
| Early Detection of Triple Negative Breast Cancer Relapse (CUPCAKE) ctDNA monitoring, 68Ga-FAPI-46-PET-CT - Triple Negative Breast Cancer | Not applicable | Recruiting | Institut Curie | 450 | 2026-01-05 | 2026-07-23 |
| Exemption of SLNB After Neoadjuvant Therapy for Triple-negative and Her2-positive Breast Cancer Exemption of SLNB - Breast Cancer (Triple Negative Breast Cancer (TNBC)), Breast Cancer | Not applicable | Active not recruiting | Xijing Hospital | 216 | 2026-01-01 | 2026-03-27 |
| The Neoadjuvant Treatment of Early High-risk Triple Negative Breast Cancer With HRD Positive With Iparomlimab and Tuvonralimab Combined With Olaparib and Paclitaxel Iparomlimab and tuvonralimab combined with olaparib and paclitaxel - Triple Negative Breast Cancer (TNBC) | Not applicable | Not yet recruiting | Harbin Medical University | 20 | 2025-12-30 | 2025-09-23 |
| Assessement of Potential Interest of [68Ga]Ga-PentixaFor PET/CT in Metastatic Triple Negative Breast Cancer Patients [68Ga]Ga-PentixaFor PET/CT - Metastatic Breast Cancer | Not applicable | Recruiting | Institut Cancerologie de l'Ouest | 12 | 2025-12-05 | 2026-01-12 |
| An Open-label Prospective Study to Evaluate the Efficacy and Safety of Pegfilgrastim in Triple-Negative Breast Cancer Patients Receiving AC Regimen Following Paclitaxel and Carboplatin as Neoadjuvant Therapy Pegfilgrastim (Neulasta) - Triple-Negative Breast Cancer | Not applicable | Recruiting | Yonsei University | 40 | 2025-10-28 | 2026-04-20 |
| Lifestyle, Exercise, And Nutrition (LEAN) Trial on Pathologic Complete Response in TNBC Exercise and Medical Nutrition - Triple Negative Breast Cancer | Not applicable | Recruiting | Yale University | 160 | 2025-10-17 | 2026-09-25 |
Showing 20 of 72. Sign in to see all of them.
Breast Neoplasms (33) · Ovarian Neoplasms (5) · Motor Activity (4) · Carcinoma, Non-Small-Cell Lung (3) · Recurrence (3) · Vulvar Neoplasms (3) · Brain Neoplasms (2) · Carcinoma, Renal Cell (2) · Colonic Neoplasms (2) · Endometrial Neoplasms (2) · Inflammatory Breast Neoplasms (2) · Melanoma (2) · Neoplasms (2) · Pathologic Complete Response (2)
Breast Diseases (72) · Neoplasms by Site (72) · Skin Diseases (72) · Skin and Connective Tissue Diseases (72) · Neoplasms (70) · Breast Neoplasms (39) · Urogenital Diseases (8) · Urogenital Neoplasms (8) · Endocrine Gland Neoplasms (7) · Endocrine System Diseases (7) · Female Urogenital Diseases (7) · Female Urogenital Diseases and Pregnancy Complications (7) · Genital Diseases (7) · Gonadal Disorders (7) · Pathological Conditions, Signs and Symptoms (7)
Standard of Care (6) · Practice Guidelines as Topic (5) · Methods (4) · Specimen Handling (4) · Cyclophosphamide (3) · Early Intervention, Educational (3) · Educational Status (3) · Interviews as Topic (3) · Diet Therapy (2) · Drug Therapy (2) · Exercise (2) · Genetic Counseling (2) · Magnetic Resonance Imaging (2) · Paclitaxel (2) · Palliative Care (2)
Institut Curie (5) · M.D. Anderson Cancer Center (4) · City of Hope Medical Center (3) · Ohio State University Comprehensive Cancer Center (3) · University of Southern California (3) · European Institute of Oncology (2) · Samsung Medical Center (2) · Sunnybrook Health Sciences Centre (2) · UNICANCER (2) · Barbara Ann Karmanos Cancer Institute (1) · Baylor Research Institute (1) · Brigham and Women's Hospital (1) · Centre Antoine Lacassagne (1) · Centre Henri Becquerel (1) · Centre Paul Strauss (1)
United States (30) · France (14) · China (6) · Italy (4) · South Korea (3) · Canada (1) · Germany (1) · Netherlands (1) · Portugal (1) · Saudi Arabia (1) · Spain (1) · Sweden (1)
Anne Reb (2) · Agustin Garcia (1) · Agustin Garcia, MD (1) · Alexandra Thomas, MD (1) · Andres Forero, MD (1) · Ayal Aizer, MD, MHS (1) · Barbro K Linderholm, MD, PhD (1) · Brea Lidia, Profesor titular UEM (1) · Charite Ricker, MS (1) · Christine Desmedt, PhD (1) · Clinton Yam (1)
PMID 17991697, PMID 20872150, PMID 21304525, PMID 21708823, PMID 21818123, PMID 23274845, PMID 24729251, PMID 25807517, PMID 28054255, PMID 28673937, PMID 28835898, PMID 29380207, PMID 29529015, PMID 30207784, PMID 30621076, PMID 30968255, PMID 31266460, PMID 31464762, PMID 32101663, PMID 32249021, PMID 33098219, PMID 33307491, PMID 33663560, PMID 34223403, PMID 34253579, PMID 34348792, PMID 34749008, PMID 35019850, PMID 35373507, PMID 35393316, PMID 35418195, PMID 35507014, PMID 35617923, PMID 35771552, PMID 35857659, PMID 35914239, PMID 36084256, PMID 36155347, PMID 36306810, PMID 36618335, PMID 37148487, PMID 37505106, PMID 37547448, PMID 37656930, PMID 37707811, PMID 37707822, PMID 38161913, PMID 38484209, PMID 39198868, PMID 39503605
P30CA033572 (3), R21CA293326 (2), 2023 (1), K08CA286755 (1), P30CA014089 (1), P30CA016672 (1), P30CA138292 (1), R01CA263532 (1), R01HL159393 (1)